SCHEMBL7242829

SCHEMBL7242829

C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@H]1CC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.58
SHBG P04278 7/20 0.58
CYP3A4 P08684 7/20 0.58
HSD17B10 Q99714 6/20 0.58
SERPINA6 P08185 6/20 0.58
TSHR P16473 6/20 0.58
MAPK1 P28482 6/20 0.58
CYP19A1 P11511 4/20 0.58
SNCA P37840 4/20 0.58
NR3C1 P04150 4/20 0.58
PGR P06401 4/20 0.58
AR P10275 4/20 0.58
MAPT P10636 4/20 0.58
GPBAR1 Q8TDU6 3/20 0.58
SIGMAR1 Q99720 3/20 0.58
CACNA1C Q13936 2/20 0.58
CYP51A1 Q16850 2/20 0.58
OR51E2 Q9H255 1/20 0.58
ALDH1A1 P00352 6/20 0.58
SMN1; SMN2 Q16637 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840982 0.86 CYP3A4 (0.55) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL6840979 0.86 CYP3A4 (0.55) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL3225890 0.81 LMNA (0.66) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL7213404 0.80 CYP19A1 (0.52) LMNASHBGCYP3A4CYP19A1NR3C1
SCHEMBL18373681 0.79 CYP3A4 (0.70) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL17808818 0.79 CYP3A4 (0.70) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL5179515 0.79 CYP3A4 (0.70) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL12859115 0.79 CYP3A4 (0.70) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL15672642 0.79 CYP3A4 (0.70) LMNASHBGCYP3A4HSD17B10SERPINA6
SCHEMBL14150045 0.79 CYP3A4 (0.70) LMNASHBGCYP3A4HSD17B10SERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030072808-A1 Immediate release eplerenone compositions THOSAR SHILPA S (US) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030072808-A1 Immediate release eplerenone compositions MC2R, NR3C2, ADRB1 LMNA 1145/4885SHBG 201/4885CYP3A4 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.